Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features
Problems of Endocrinology · 2023
DOI: 10.14341/probl13301 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Problems of Endocrinology, 2023. Verfasst von A Chevais und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre. Hauptthemen laut MEDLINE: Cushing Syndrome, Hypertension, Osteoporosis. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND : Primary bilateral macronodular adrenal hyperplasia (PBMAH) is characterized by bilateral benign adrenocortical lesions, which in some cases lead to Cushing syndrome (CS). Due to the low detection, non-specific, erased clinical picture and slow, long-term progression, it is difficult to assess the true prevalence of PBMAH. This also leads to fairly limited literature data. A detailed analysis of biochemical, imaging parameters, the clinical presentations, in particular, an assessment of the course of comorbidities (arterial hypertension (AH), diabetes (DM), osteoporosis), is necessary to develop an algorithm for managing patients with PBMAH. AIM : Analysis of clinical and laboratory characteristics of patients with various forms of PBMAH. MATERIALS AND METHODS : A single-center, retrospective, observational, cross-sectional study was carried out. This study included 110 patients with PBMAH who got referred to the National Research Center for Endocrinology in the period from 2013–2023. We carried out comparative and correlation analysis of hormonal (plasma cortisol concentrations after 1 mg dexamethasone (1-mg DST), urinary free cortisol (СКМ), ACTH), biochemical (glycated hemoglobin), radiological data (nodular tissue volume), course of comorbidities (metabolic syndrome, DM, AH, osteoporosis) in three groups of patients: with overt CS, mild autonomous cortisol excess (MACE) and comorbid diseases, and patients with PBMAH without hormonal activity. RESULTS : Among 110 patients 79.1% were women, median age — 60 [51; 68]. The proportion of hormonally inactive forms of PBMAH was 37.3%, the overt CS and MACE was detected in 25.4 and 37.3% consequently. According to the hormonal examination data: the cortisol level during 1-mg DST was 173.8 nmol/l [86.0; 441.0], ACTH — 3.35 pg/ml [1.00; 8.00], СКМ — 445.5 [249.0; 900.0]. Statistically significant positive moderate correlations were found between the volume of nodular tissue and the level of cortisol after PDT1 (r=0.40, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology Research Centre.
Zitieren
APA
Chevais, A., Elfimova, A. R., & Beltsevich, D. G. (2023). Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features. Problems of Endocrinology. https://doi.org/10.14341/probl13301
Vancouver
Chevais A, Elfimova AR, Beltsevich DG. Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features. Problems of Endocrinology. 2023. doi:10.14341/probl13301
BibTeX
@article{Chevais2023,
author = {Chevais, A and Elfimova, A R and Beltsevich, D G},
title = {Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features},
journal = {Problems of Endocrinology},
year = {2023},
doi = {10.14341/probl13301}
}
EUVIMED